<p>(<b>a</b>) The ABCG2 transcript in CML patients was determined by real-time RT-PCR using the RQ values with <i>GAPDH</i> mRNA as the endogenous control. In contrast to normal donors, no substantial difference in the ABCG2 transcript levels was detected in CML patients. *<i>P</i><0.05. (<b>b</b>) ABCG2+ cells were labeled by CD338-PE and detected by FACS, using IgG2b-PE as the isotype control. There were no significant differences among the groups. *<i>P</i><0.05. (c) Significantly higher percentages of SP cells were observed in CML blasts at AP/BP using flow cytometry. *<i>P</i><0.05.</p
<p>MDDCs were transfected with ABCG2 siRNA or control siRNA for 24 hours and then stimulated with LP...
<p>Quantitative RT-PCR was performed on B cells from 11 healthy donors and 50 representative CLL pat...
<p>Quantitative RT-PCR of <i>AML1</i> mRNA levels of normal subjects, CML patient samples, and CML c...
Imatinib mesylate (IM) therapy for chronic myeloid leukemia (CML) has transformed the treatment of t...
<p>(A, B) Immunofluorescence staining for mES-R1 cells transfected with CMS-ABCG2. The GFP marks tra...
<p>(<b>a</b>) Endogenous levels of <i>PTEN</i> mRNA in CML patients and normal donors were examined ...
<p>(A) PBDCs were purified from peripheral blood by PBDC isolation kit. Surface ABCG2 expression lev...
<p>Arg1 expression (<b>A</b>) and activity (<b>B</b>) were significantly increased in CML PMNs more ...
<p>(<b>a</b>) BCR-ABL transcript expression was upregulated in all drug-resistant cells, whereas hig...
Within the EURO-SKI trial, 132 chronic phase CML patients discontinued imatinib treatment. RNA was i...
The nature of BCR/ABL hybrid mRNA was analyzed by RT-PCR in cells from 33 patients (22 males, 11 fem...
Bcr-abl mRNA expression was studied in patients with chronic myeloproliferative disorders (CMPD) by ...
<p><b>(A)</b> qPCR showing <i>c-kit</i> expression in myeloid leukemia cell lines. CML-BC: chronic m...
<p>Immunoblot analysis of cell lysates of PBMCs derived from CLL patients (P) and healthy donors (H)...
The Philadelphia (Ph’) chromosome in chronic myelogenous leukemia (CML) results in fusion of the bcr...
<p>MDDCs were transfected with ABCG2 siRNA or control siRNA for 24 hours and then stimulated with LP...
<p>Quantitative RT-PCR was performed on B cells from 11 healthy donors and 50 representative CLL pat...
<p>Quantitative RT-PCR of <i>AML1</i> mRNA levels of normal subjects, CML patient samples, and CML c...
Imatinib mesylate (IM) therapy for chronic myeloid leukemia (CML) has transformed the treatment of t...
<p>(A, B) Immunofluorescence staining for mES-R1 cells transfected with CMS-ABCG2. The GFP marks tra...
<p>(<b>a</b>) Endogenous levels of <i>PTEN</i> mRNA in CML patients and normal donors were examined ...
<p>(A) PBDCs were purified from peripheral blood by PBDC isolation kit. Surface ABCG2 expression lev...
<p>Arg1 expression (<b>A</b>) and activity (<b>B</b>) were significantly increased in CML PMNs more ...
<p>(<b>a</b>) BCR-ABL transcript expression was upregulated in all drug-resistant cells, whereas hig...
Within the EURO-SKI trial, 132 chronic phase CML patients discontinued imatinib treatment. RNA was i...
The nature of BCR/ABL hybrid mRNA was analyzed by RT-PCR in cells from 33 patients (22 males, 11 fem...
Bcr-abl mRNA expression was studied in patients with chronic myeloproliferative disorders (CMPD) by ...
<p><b>(A)</b> qPCR showing <i>c-kit</i> expression in myeloid leukemia cell lines. CML-BC: chronic m...
<p>Immunoblot analysis of cell lysates of PBMCs derived from CLL patients (P) and healthy donors (H)...
The Philadelphia (Ph’) chromosome in chronic myelogenous leukemia (CML) results in fusion of the bcr...
<p>MDDCs were transfected with ABCG2 siRNA or control siRNA for 24 hours and then stimulated with LP...
<p>Quantitative RT-PCR was performed on B cells from 11 healthy donors and 50 representative CLL pat...
<p>Quantitative RT-PCR of <i>AML1</i> mRNA levels of normal subjects, CML patient samples, and CML c...